Follow-The-Filings

Security

ASMB

Assembly Biosciences Inc. · COM NEW

Equity holders as of 2026 Q1 (each manager’s latest book)

7 owners max 0.2% (Farallon Capital Manageme...)

grid → activity →
owners 7
max % 0.2%
tracked value $75M
qoq A 4 R 2

holders

sorted by % of portfolio · long equity only

manager % port activity shares value history
Farallon Capital Management LLC 2026 Q1 0.2% — 1,227,590 $34M hist
Steve Cohen - Point72 Asset Management, L.P. 2026 Q1 0.0% Reduce -0.01 pp 344,105 $10M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Add 0.00 pp 572,898 $19M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Add 0.00 pp 233,650 $6M hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% Add 0.00 pp 163,400 $5M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Reduce 0.00 pp 25,437 $706 hist
Renaissance Technologies LLC 2026 Q1 0.0% Add 0.00 pp 15,651 $434 hist

7 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue — — $72.3M
Gross profit — — —
Gross margin — — —
Net income -$61.23M -$40.18M -$6.12M
Net margin * — — -8.5%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $133.79M $115.5M $254.55M
Total non-current assets * $3.04M $3.66M $3.04M
Total assets $136.82M $119.17M $257.59M
Total current liabilities $39.22M $47.8M $48.78M
Total non-current liabilities * $56.5M $38.01M $2.06M
Total equity $41.1M $33.36M $206.75M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $22.74M -$51.12M -$41.09M
Cash from investing -$69.14M $40.17M -$113.47M
Cash from financing $13.82M $29.45M $174.67M
Net change in cash -$32.58M $18.5M $20.11M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders